Consistently, overexpression of TRIM71 can suppress, whereas ablation of TRIM71 can boost, the growth and metastasis of ovarian cancer cells in vitro and the growth of ovarian cancer in vivo by influencing mtp53 activity. Here, TRIM71 is linked to ovarian cancer.